← Back
$DFTX All transactions

Definium Therapeutics, Inc.

A

$ Value

$0

Shares

125,000

Price

$0

Filed

Feb 5

Insider

Name

Sullivan Mark

Title

Chief Legal Officer

CIK

0001331843

Roles

Officer

Transaction Details

Transaction Date

2026-02-03

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

407,576

Footnotes

These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one common share of the Issuer. The RSUs vest in 16 equal quarterly installments beginning on June 1, 2026, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date.

Filing Info

Accession No.

0001193125-26-039579

Form Type

4

Issuer CIK

0001813814

Sullivan Mark's History

Date Ticker Type Value
2026-03-25 DFTX $198K
2026-02-03 DFTX A $0
2025-12-26 MNMD $148K
2025-09-25 MNMD $110K
2025-06-25 MNMD $78K

Other Insiders at DFTX (90d)

Insider Bought Sold Last
Sullivan Mark
Chief Legal Officer
$198K 2026-03-25
Roberts Brandi
Chief Financial Officer
2026-02-03
Adsett Roger 2026-01-29
Wiley Matthew T.
Chief Commercial Officer
2026-02-03
Barrow Robert
Chief Executive Officer
$451K 2026-03-25
Karlin Daniel
Chief Medical Officer
$148K 2026-03-25